Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines

被引:52
|
作者
Gawad, Nagwa M. Abdel [1 ]
Amin, Noha H. [2 ]
Elsaadi, Mohammed T. [2 ]
Mohamed, Fatma M. M. [2 ]
Angeli, Andrea [3 ]
De Luca, Viviana [4 ]
Capasso, Clemente [4 ]
Supuran, Claudiu T. [3 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
[2] Beni Suef Univ, Dept Med Chem, Fac Pharm, Bani Suwayf 62514, Egypt
[3] Univ Florence, Dipartimento Neurofarba, Sez Sci Farmaceut & Nutraceut, Via U Schiff 6, I-50019 Florence, Italy
[4] CNR, Ist Biosci & Biorisorse, Via Pietro Castellino 81, I-80125 Naples, Italy
关键词
Carbonic anhydrase; Inhibitor; Sulfonamide; Antitumor; Cytotoxic agent; RAY CRYSTAL-STRUCTURE; HUMAN ISOFORM-II; ISOZYME-II; SELECTIVE INHIBITORS; THERAPEUTIC APPLICATIONS; SULFONAMIDE DERIVATIVES; XII INHIBITORS; BINDING; ANTICANCER; HYPOXIA;
D O I
10.1016/j.bmc.2016.05.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 4-(thiazol-2-ylamino)-benzenesulfonamides was synthesized and screened for their carbonic anhydrase (CA, EC 4.2.1.1) inhibitory and cytotoxic activity on human breast cancer cell line MCF-7. Human (h) CA isoforms I, II and IX were included in the study. The new sulfonamides showed excellent inhibition of all three isoforms, with K(I)s in the range of 0.84-702 nM against hCA I, of 0.41-288 nM against hCA II and of 5.6-29.2 against the tumor-associated hCA IX, a validated anti-tumor target, with a sulfonamide (SLC-0111) in Phase I clinical trials for the treatment of hypoxic, metastatic solid tumors overexpressing CA IX. The new compounds showed micromolar inhibition of growth efficacy against breast cancer MCF-7 cell lines. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3043 / 3051
页数:9
相关论文
共 50 条
  • [21] Dinuclear triphenylphosphinegold(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines
    Barreiro, Elena
    Casas, Jose S.
    Couce, Maria D.
    Sanchez, Agustin
    Sanchez-Gonzalez, Angeles
    Sordo, Jose
    Varela, Jose M.
    Vazquez Lopez, Ezequiel M.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2010, 104 (05) : 551 - 559
  • [22] Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae - and -class enzymes
    Bua, Silvia
    Berrino, Emanuela
    Del Prete, Sonia
    Murthy, Vallabhaneni S.
    Vijayakumar, Vijayaparthasarathi
    Tamboli, Yasinalli
    Capasso, Clemente
    Cerbai, Elisabetta
    Mugelli, Alessandro
    Carta, Fabrizio
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 1125 - 1136
  • [23] Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
    George, Riham F.
    Said, Mona F.
    Bua, Silvia
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2020, 95
  • [24] Heteronuclear gold(I)-silver(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines
    Barreiro, Elena
    Casas, Jose S.
    Couce, Maria D.
    Sanchez, Agustin
    Sordo, Jose
    Vazquez-Lopez, Ezequiel M.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2014, 131 : 68 - 75
  • [25] Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity
    Kumar, Rajiv
    Sharma, Vikas
    Bua, Silvia
    Supuran, Claudiu T.
    Sharma, Pawan K.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 1187 - 1194
  • [26] Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines
    Somprasong Saenglee
    Sanun Jogloy
    Aran Patanothai
    Mark Leid
    Thanaset Senawong
    Pharmacological Reports, 2016, 68 : 1102 - 1110
  • [27] Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines
    Saenglee, Somprasong
    Jogloy, Sanun
    Patanothai, Aran
    Leid, Mark
    Senawong, Thanaset
    PHARMACOLOGICAL REPORTS, 2016, 68 (06) : 1102 - 1110
  • [28] Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors
    Swain, Baijayantimala
    Digwal, Chander Singh
    Angeli, Andrea
    Alvala, Mallika
    Singh, Priti
    Supuran, Claudiu T.
    Arifuddin, Mohammed
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (21)
  • [29] Benzoxazolone and benzothiazolone combretastatin A-4 analogs with potential cytotoxic activity against breast cancer cell lines
    Atanasov, G.
    Stateva, S.
    Gerova, M.
    Petrov, O.
    Apostolova, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S125 - S125
  • [30] Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines
    Sala, Marina
    Chimento, Adele
    Saturnino, Carmela
    Gomez-Monterrey, Isabel M.
    Musella, Simona
    Bertamino, Alessia
    Milite, Ciro
    Sinicropi, Maria Stefania
    Caruso, Anna
    Sirianni, Rosa
    Tortorella, Paolo
    Novellino, Ettore
    Campiglia, Pietro
    Pezzi, Vincenzo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4990 - 4995